Geffken Daniel E. insider trades
Geffken Daniel E. has filed 8 Form 4s with the SEC that we hold, for CalciMedica, Inc. (CALC) (Interim CFO), Cero Therapeutics Holdings, INC. (CERO) (Chief Financial Officer), Windtree Therapeutics INC /DE/ (WINT) (Director) and Eloxx Pharmaceuticals, Inc. (ELOX) (INTERIM CFO), among 5 companies in all. Across all of them we count 1 purchase worth $36.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 50,000 shares of Eloxx Pharmaceuticals, Inc. worth $36.0K, dated 2021-11-29. The first filing on our record is dated 2021-10-12 and the latest 2024-05-20.
CalciMedica, Inc. (CALC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Cero Therapeutics Holdings, INC. (CERO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Windtree Therapeutics INC /DE/ (WINT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Eloxx Pharmaceuticals, Inc. (ELOX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-11-29 | P, purchase reported on Form 4 | 50,000 | $36.0K | 2021-12-01 | SEC |
ProMIS Neurosciences Inc. (PMN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1314756) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
